About Sollers

Sollers is a graduate school located in New Jersey, specializing in clinical research, drug safety and pharmacovigilance training.

Our graduate certificate and masters programs cover a wide range of subjects tailored to this fast growing industry, and our graduates go on to highly successful careers in the pharmaceuticals industry and healthcare industries.

  • HOURS
  • Monday - Thursday | 10 AM - 7 PM
  • Friday | 12 PM - Midnight
  • Saturday | 12 PM - Midnight
  • Sunday | Closed
  • OPEN 24/7 - sollers.edu
    • PHONE
    • (848) 299-5900
    • Location
    • 100 Menlo Park, Suite 550
      Edison New Jersey 08837 -2488

Location

Call Us Now: 848 299-5900

Sollers Blog

Doctor Dan

I am a medical graduate and have a passion for life science disciplines. Would like to share expertise thorough my writings.

Recent Posts

Clinical Research and the impact on humans

Posted by Doctor Dan on Nov 16, 2017 12:59:25 PM

Clinical trials are carefully designed to be as safe as possible for everyone taking part, whichever treatment they receive. Some trials will involve very little risk. In others there may be some side effects from treatments, and finding out more about these side effects is one of the reasons we have trials, says a healthtalk.com report.

Read More

Topics: Clinical Research

Harnessing Technology through Optimization of Patient Engagement

Posted by Doctor Dan on Nov 2, 2017 3:40:46 PM

The combined objective of life science firms and the end-users of healthcare are the enhanced patient outcomes. Often, this has become cumbersome, as the patients find it difficult to browse through the rigmaroles of the healthcare system. For those who live with ailments, the experience can be traumatic, to say the least.

Read More

Topics: Clinical Research

Outcome Health, Harward Health Publications forge alliance to improve digital platforms in clinics

Posted by Doctor Dan on Oct 19, 2017 3:06:21 PM

Fresh off a $500 million first financing round in late May this year, Outcome Health has already set out to improve its health intelligence offerings with the help of a new collaborator: Harvard Health Publications, Angus LLu, Associate Editor, writes on Fiercebiotech.com.

Read More

Topics: Clinical Research

Healthcare Data Science for Quality Improvement and Patient Safety

Posted by Doctor Dan on Oct 17, 2017 1:47:00 PM

In order to reap the benefits of data, it calls for evolving an organization-wide data science strategy. What with many other segments such as banking has adopted Data Science, health care is an exception. With the absence of a data science strategy, healthcare firms find it difficult to handle the increasing volume of data. Also individual clinicians find it cumbersome to improve the safety, quality and efficiency of the care they provide. An effective data science strategy for health care organizations is therefore, the need of the hour, says, a catalyst.nejm.org report. Data Science has five key components.

Read More

Topics: Data Science

eTMFs Are Transforming the Pharmaceutical Industry

Posted by Doctor Dan on Oct 9, 2017 2:50:27 PM

According to a last year’s research on checking the pulse of the pharmaceutical industry’s use of trial master file (TMF) and collating feedback from 217 TMF managers from across the globe shows humongous change is under way as the industry shifts from passive to active TMF management and adopts advanced electronic TMF (eTMF) applications to improve inspection readiness and shorten clinical trial times, Rik van Mol, Vice President of R&D Strategy, Europe, at Veeva Systems, responsible for the Veeva Vault R&D suite of applications writes on pharmexec.com.

Read More

Topics: Clinical Research

Ethics of Human Research Subjects, Synopsis

Posted by Doctor Dan on Oct 4, 2017 12:57:08 PM

As early as January 18, this year, the US Department of Health and Human Services (HHS), via the Office of Human Research and Protection (OHRP), released the final regulations (the Final Rule), bringing about notable changes to the Federal Policy for the Protection of Human Subjects (The Common Rule), according to a Hallrender.com report.

Read More

Topics: Drug Safety

Global Pharmaceutical Industry to Grow at a CAGR of 4-7% during the next five years

Posted by Doctor Dan on Sep 28, 2017 1:36:20 PM

Total spending on medicines is projected to touch $1.5 trillion by 2021, up 33% from 2016 levels even as annual growth moderates from the record pace set in 2014 and 2015, writes Patricia Van Arnum on connect.dcat.org. The recent analysis by QuintilesIMS forecasts that the global pharmaceutical industry will grow at a compound annual growth rate of 4-7% during the next five years, down from the nearly 9% growth level seen in 2014 and 2015.

Read More

Topics: Drug Safety

Patient Data Access is a Right Guaranteed by HIPAA Regulations

Posted by Doctor Dan on Sep 22, 2017 12:05:12 PM

Individuals have an inherent right to access their own health information. Patient data access can be a critical tool for proper care, but both providers and patients often face confusion about how HIPAA regulations impact the exchange and release of protected health information (PHI).

Read More

Topics: Clinical Research

Environment Monitoring Using Risk Based Approach - 2

Posted by Doctor Dan on Sep 19, 2017 12:58:22 PM

In the Clinical Research arena, the Environmental Monitoring (EM) Program - comprising of viable and non-viable monitoring elements – is designed to routinely monitor particulates as well as micro-organisms in key spears of pharmaceutical manufacturing facility, especially in the aseptic processing areas. While the viable or micro-biological monitoring is replete with routine monitoring of the manufacturing environment for the trace of micro-organisms, the non-viable particulate monitoring, calculates the airborne particle count and further offers inputs on the routine maintenance of the clean room air classification.

Read More

Topics: Clinical Research

Amazon might foray into Clinical Trials Segment

Posted by Doctor Dan on Sep 18, 2017 12:43:12 PM

The global e-commerce Major Amazon has made many awestruck with its foray into the hitherto untapped area of healthcare. Although, the company has a perfect platform for selling any product under the sun, including pharmaceutical items, but then why should it get into healthcare segment is the question that begs an answer, according to medium.com report.

Read More

Topics: Clinical Research